Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
XRF ScientificASX:XRF 96 Days Payable is 19.25 as of Jun. 2026, which is 45% above its 10-year median of 13.24. GuruFocus rates ASX:XRF with a GF Score™ of 96/100 and a GF Value™ of A$1.78 (Fairly Valued). The stock has 1 warning sign investors should review. Among 501 Conglomerates companies, XRF Scientific ranks worse than 92.61% on this metric.
The historical rank and industry rank for XRF Scientific's Days Payable or its related term are showing as below:
ASX:XRF'
s Days Payable Range Over the Past 10 Years
Min: 11.44 Med: 13.24 Max: 40.27
Current: 16.7
During the past 13 years, XRF Scientific's highest Days Payable was 40.27. The lowest was 11.44. And the median was 13.24.
ASX:XRF's Days Payable is ranked worse than 92.61% of 501
companies
in the Conglomerates industry
Industry Median: 56.04
vs ASX:XRF: 16.70
XRF Scientific's Days Payable
declined
from Jun. 2025 (25.03) to Jun. 2026 (19.25).
It may suggest that XRF Scientificaccelerated paying its suppliers.
The historical data trend for XRF Scientific's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Conglomerates subindustry, XRF Scientific's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
XRF Scientific Days Payable vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, XRF Scientific's Days Payable distribution charts can be found below:
* The bar in red indicates where XRF Scientific's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
XRF Scientific's Days Payable for the fiscal year that ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XRF Scientific (ASX:XRF) has a Days Payable of 19.25 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on XRF Scientific and its competitors. This is 45% above median its historical median of 13.24. Over the past decade, XRF Scientific's Days Payable has ranged from 11.44 to 40.27. According to the industry distribution chart, XRF Scientific ranks #464 out of 501 companies in the Conglomerates industry, placing it in the top 92.6%.
Is XRF Scientific's Days Payable too high?
XRF Scientific's current Days Payable of 19.25 is 45% above median its 10-year median of 13.24. Over the past 10 years, this metric has ranged from a low of 11.44 to a high of 40.27. The Conglomerates industry median Days Payable is 56.04. XRF Scientific's value of 19.25 is 65.6% below this industry median. Based on the distribution chart, XRF Scientific ranks #464 out of 501 companies in the Conglomerates industry, which is in the bottom quartile relative to peers. Overall, XRF Scientific has a GF Score™ of 96/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does XRF Scientific's Days Payable compare to MMM and HON?
According to the Conglomerates industry distribution chart, XRF Scientific ranks #464 out of 501 companies for Days Payable. This places XRF Scientific in the lower half of its industry. The industry median Days Payable is 56.04. XRF Scientific's value of 19.25 is 65.6% below this benchmark. Historically, XRF Scientific's own Days Payable has ranged from 11.44 to 40.27 over the past decade. While the company's 10-year median is 13.24 vs. the industry median of 56.04, XRF Scientific has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Conglomerates company?
The median Days Payable among Conglomerates companies is 56.04, based on 501 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. XRF Scientific's current Days Payable of 19.25 is 65.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on XRF Scientific and its competitors. For the Conglomerates industry, the median Days Payable is 56.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. XRF Scientific's current Days Payable is 19.25, which is 45% above median its own 10-year median of 13.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is XRF Scientific stock overvalued right now?
Based on GuruFocus' analysis, XRF Scientific (ASX:XRF) is currently considered Fairly Valued. The stock's GF Value™ is A$1.78, compared to a current price of A$1.87 — trading 5.1% above its estimated fair value. The current Days Payable is 19.25, which is 45% above median its 10-year median of 13.24 and 65.6% below the Conglomerates industry median of 56.04. XRF Scientific's overall GF Score™ is 96/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For XRF Scientific (ASX:XRF), the current Days Payable is 19.25 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is XRF Scientific (ASX:XRF) Overvalued in 2026?
Based on GuruFocus' analysis, XRF Scientific stock appears to be overvalued.
The current stock price of A$1.87 is trading 5.1% above its estimated GF Value™ of A$1.78.
GuruFocus considers XRF Scientific to be Fairly Valued.
Key valuation signals for ASX:XRF:
Days Payable: 19.25 (45% above median its 10-year median of 13.24)
GF Value™: A$1.78 vs. price of A$1.87 (5.1% above fair value)
Industry Position: 65.6% below the Conglomerates median (#464 of 501)
No single metric tells the full story. See the ASX:XRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
XRF Scientific Ltd is engaged in the business of manufacturing and marketing precious metal products, specialized chemicals and instruments for the scientific, analytical and mining industries. It operates through the following segments: Capital Equipment, Precious Metals, and Consumables. The company generates maximum revenue from the Capital Equipment segment that Manufactures sample preparation products and analytical instruments. Geographically, it derives a majority of revenue from Australia and also has a presence in Canada and Europe. Some of its product includes Electric Fusion Machines; Fusion Flux; Crushing and Pulverising, platinum lab ware and others.
96GF Score
Get the complete analysis for ASX:XRF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:XRF has been successfully added to your 
